UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000005584
Receipt number R000006212
Scientific Title Analysis of genotypes associated with the treatment effects of Lucentis for age-related macular degeneration
Date of disclosure of the study information 2011/05/16
Last modified on 2016/12/09 15:55:48

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Analysis of genotypes associated with the treatment effects of Lucentis for age-related macular degeneration

Acronym

ANGEL study

Scientific Title

Analysis of genotypes associated with the treatment effects of Lucentis for age-related macular degeneration

Scientific Title:Acronym

ANGEL study

Region

Japan


Condition

Condition

age-related macular degeneration

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

Searching for genetic polymorphisms associated with the prognosis after Ranibizumab treatment for age-related macular degeneration

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

visual acuity change at 12 months after the first treatment

Key secondary outcomes

disappearance of retinal exudative change at 3 months, visual acuity change at 3 months, interval for additional treatment, and number of treatment during 12 months


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Patients receive three monthly intravitreal injections of ranibiumab (0.5mg) and followed up monthly for 12 months. Repeat injections were given to patients who showed insufficient effects of treatment or recurrence.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Treatment naive active angiographically subfoveal choroidal neovascularization associated with age-ralated macular degeneration with best corrected visual acuity of 32/40 to 20/400

Key exclusion criteria

Previous treatment with photocoagulation, surgery, photodynamic therapy, Transpupillary thermotherapy, radiation

Subfoveal fibrosis or atrophy

History of vitrectomy

Intraocular surgery within 2 months

CNV in either eye due to other causes, such as ocular histo-plasmosis, trauma, or pathological myopia

Aphakia or absence of the posterior capsule in the study eye unless it resulted from yttrium aluminum garnet (YAG) posterior capsulotomy in association with prior posterior chamber intraocular lens implantation.

Target sample size

600


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Nagahisa Yoshimura

Organization

Kyoto University Graduate School of Medicine

Division name

Department of Ophthalmology and Visual Sciences

Zip code


Address

54 Kawahara, Shogoin, Sakyo, Kyoto, Japan

TEL

075-751-3248

Email

nagaeye@kuhp.kyoto-u.a.cjp


Public contact

Name of contact person

1st name
Middle name
Last name Kenji Yamashiro

Organization

Kyoto University Graduate School of Medicine

Division name

Department of Ophthalmology and Visual Sciences

Zip code


Address

54 Kawahara, Shogoin, Sakyo, Kyoto, Japan

TEL

075-751-3248

Homepage URL


Email

yamashro@kuhp.kyoto-u.ac.jp


Sponsor or person

Institute

Kyoto University Graduate School of Medicine, Department of Ophthalmology and Visual Sciences

Institute

Department

Personal name



Funding Source

Organization

MHLW

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

福島県立医科大学(福島)、群馬大学(群馬)山梨大学(山梨)、埼玉医科大学(埼玉)、東京医療センター(東京)、東京大学(東京)、名古屋大学(名古屋)、名古屋市立大学(名古屋)、京都大学(京都)、関西医科大学眼科(大阪)、大阪大学(大阪)、神戸大学(神戸)、島根大学(島根)、大塚眼科病院(北海道)、聖隷浜松病院(静岡)、宮田眼科医院(宮崎)


Other administrative information

Date of disclosure of the study information

2011 Year 05 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 05 Month 10 Day

Date of IRB


Anticipated trial start date

2011 Year 09 Month 01 Day

Last follow-up date

2015 Year 12 Month 31 Day

Date of closure to data entry

2015 Year 12 Month 31 Day

Date trial data considered complete

2015 Year 12 Month 31 Day

Date analysis concluded

2016 Year 06 Month 01 Day


Other

Other related information



Management information

Registered date

2011 Year 05 Month 10 Day

Last modified on

2016 Year 12 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006212


Research Plan
Registered date File name
2016/12/09 研究計画書.docx

Research case data specifications
Registered date File name
2016/12/09 仕様書.docx

Research case data
Registered date File name
2016/12/09 研究症例.docx